Dear Colleagues,

Cancer is a leading cause of morbidity and mortality worldwide, and the development of effective and targeted therapies is a major focus of current cancer research. There are a variety of modern approaches to the treatment of cancer, including chemotherapy, targeted therapies, immunotherapies, gene therapies, targeted radiotherapy, and targeted surgery.

Targeted cancer therapies are designed to specifically act on the molecular and cellular abnormalities that drive cancer growth and proliferation, and have the potential to offer improved efficacy and reduced side effects compared to traditional chemotherapy.

It is important to note that targeted therapies are typically used in combination with other cancer treatments, such as chemotherapy or radiation therapy, and the choice of therapy will depend on the specific type of cancer being treated.

Overall, modern anticancer approaches aim to specifically target the abnormalities that drive cancer growth and proliferation, and offer the potential for improved efficacy and reduced side effects compared to traditional chemotherapy.

This Special Issue will include the following topics:

• Precision medicine
• Targeted therapy, gene-editing therapies
• Immuno-oncology targets, monoclonal antibodies, small molecule inhibitors
• DNA damage response (DDR) targets
• Oncogenic kinases
• Autophagy targets
• Epigenetic targets

Dr. Milena Georgieva

Guest Editor